Manufacturer
Esteve Pharmaceuticals
Pharmaceutical manufacturer based in Spain
Spain
- Products listed
- 6
- Molecules
- 4
- Therapy areas
- 3
Esteve Pharmaceuticals is a pharmaceutical manufacturer based in Spain. MedsAcross lists 6 of its products across 4 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- Spain
- Indian manufacturer
- No
- Also listed as
- Esteve Pharmaceuticals, S.A., Esteve Pharmaceuticals GmbH, Esteve Pharmaceuticals, S.A.
- EU marketing authorisation holder
- YesSource: European Medicines Agency
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Esteve Pharmaceuticals products through licensed channels, with the documents your regulator needs.
Pain and anaesthesia
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Prialt 100 mcg/1 mL injectionIntrathecal Cold chain | Ziconotide | US FDA | Available on request |
| Prialt 500 mcg/20 mL injectionIntrathecal Cold chain | Ziconotide | US FDA | Available on request |
| Prialt 500 mcg/5 mL injectionIntrathecal Cold chain | Ziconotide | US FDA | Available on request |
Oncology
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Lysodren 500 mg tabletOral | Mitotane | US FDA | Available on request |
Contrast media and diagnostics
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Metopirone 250 mg capsuleOral | Metyrapone | US FDA | Available on request |
Other products
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Quzyttir 10 mg/1 mL injectionIntravenous | Cetirizine | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Esteve Pharmaceuticals
Send a request for any of these products. We confirm the licensed source, documents and lead time.